.png
)
27th February, 2025 In a major step towards making essential medicines more affordable, the National Pharmaceutical Pricing Authority (NPPA) has directed pharmaceutical manufacturers and marketers to reduce the Maximum Retail Price (MRP) of specific drugs that recently received customs duty…
26 February, 2025 The Central Drugs Standard Control Organization (CDSCO) has issued a circular dated 24.02.2025 for all the manufacturers of Category D Fixed Dose Combinations (FDCs). CDSCO has previously provided two separate pathways for the approvals of Category D…
25th February,2025 The pharmaceutical industry operates under strict regulations to ensure the safety, efficacy, and quality of drugs available in the market. One of the critical aspects of drug classification in India is the definition of a "New Drug" under…
Feb 22, 2025 In a major regulatory move, India's Central Drug Regulator (CDSCO) have ordered the immediate withdrawal of manufacturing and export permissions for all Tapentadol-Carisoprodol combinations. This decisive action comes in response to growing concerns over their misuse…
The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, Government of India, has taken another significant step towards digital transformation. As per the circular dated 12th February 2025, CDSCO has introduced an online provision for…